Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Type 1 diabetes
Pharma
Novo to gradually phase out production of human insulin pens
As sales of Novo Nordisk’s GLP-1 drugs continue to soar, the Danish drugmaker is once again adjusting its insulin production priorities.
Fraiser Kansteiner
Nov 14, 2024 2:13pm
FDA expert panel spurns Lexicon's approval bid in type 1 diabetes
Nov 1, 2024 11:24am
In restructuring move, Lexicon to lay off 50% of field force
Aug 13, 2024 3:34pm
Novo Nordisk's once-weekly insulin gets a thumbs-down from FDA
Jul 11, 2024 10:05am
Novo Nordisk's weekly insulin will get FDA adcomm review
Apr 29, 2024 11:08am
To boost production of T1D candidates, Vertex jumps to TreeFrog
Apr 24, 2024 7:25am
